Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Cantor Fitzgerald Analyst Maintains Neutral Rating and 250 Price Target on Zscaler NASDAQZS

Elaine Mendonca by Elaine Mendonca
February 13, 2024
in Breaking News
0
Technology Artificial intelligence Market Capitalization
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

On February 13, 2024, Cantor Fitzgerald analyst Yi Fu Lee expressed their stance on Zscaler (NASDAQ:ZS) by reiterating a Neutral rating and keeping the price target at $250. The analysis and insights provided by Cantor Fitzgerald played a significant role in forming this viewpoint on Zscaler’s stock performance.

ZS Stock Price Drops Significantly: Factors and Analysis for Investors

On February 13, 2024, ZS experienced a significant drop in its share price. The stock decreased by $9.96 since the market last closed, representing a 3.92% decline. ZS opened at $240.72, which was $13.14 lower than its previous closing price. Such a large gap can be attributed to various factors, such as market sentiment, news releases, or investor reactions to certain events. Investors who closely follow ZS may have been surprised by this drop in share price, especially considering the stock’s positive momentum and its position above the 200-day simple moving average. It is important to note that stock prices can be influenced by a multitude of factors, including market trends, economic indicators, company news, and investor sentiment. Investors and traders should continue to monitor ZS closely to assess whether this drop in share price is a temporary setback or a more significant trend. Conducting thorough research and analysis, considering both technical and fundamental factors, can assist in making informed investment decisions. Disclaimer: The information provided in this article is solely for informational purposes and should not be considered as financial advice.

ZS Stock Shows Strong Revenue Growth Despite Continued Net Losses: Analysis and Outlook for February 13, 2024

On February 13, 2024, ZS stock demonstrated strong revenue growth but continued to report net losses. The company’s total revenue for the past year was $1.62 billion, representing a significant increase of 48.22% compared to the previous year. Additionally, ZS’s total revenue for the first quarter of 2024 amounted to $496.70 million, showing a 9.16% increase compared to the previous quarter.

However, ZS also reported net losses for the same periods. The net income for the past year was -$202.34 million, which represents a 48.16% increase compared to the previous year. In the first quarter of 2024, the net income was -$33.48 million, showing a decrease of 9.16% compared to the previous quarter.

Although ZS experienced an increase in net losses, the growth rate was significantly lower than the revenue growth rate. This suggests that the company’s operational costs and expenses are increasing at a slower pace compared to its revenue growth. While net losses are still a concern, the smaller decrease in net income compared to the previous quarter indicates that ZS is making progress in managing its costs.

The earnings per share (EPS) for ZS stock also followed a similar pattern. The EPS for the past year was -$1.40, showing a 49.6% increase compared to the previous year. In the first quarter of 2024, the EPS was -$0.23, indicating an 8.26% decrease compared to the previous quarter.

Overall, ZS stock demonstrated strong revenue growth on February 13, 2024, with a 48.22% increase in total revenue compared to the previous year. However, the company continued to report net losses, albeit with a smaller decrease in net income compared to the previous quarter. The positive revenue growth and improving EPS indicate that ZS is making progress in its financial performance, but investors will closely watch the company’s ability to achieve profitability in the long run.

Tags: ZS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Trading online

Earning 500 per Month from Kraft Heinz Stock Dividends Calculating the Necessary Investment

Finance_ stocks to buy

Determining the Current Value of a 1000 Investment in Bank of America

Watsco Inc Delivers Impressive Financial Results for Fourth Quarter and FullYear 2023

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com